Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oral anaerobic root canal bacteria comprise a diverse group of microorganisms that colonize the necrotic pulp space of teeth. These bacteria are primarily obligate anaerobes, including genera such as Porphyromonas, Prevotella, and Fusobacterium (Siqueira & Rôças, 2009, PubMed). They typically exist within complex biofilms, which provide protection from host immune cells and increase resistance to antimicrobial agents (Nair, 2006, PubMed). The metabolic byproducts and endotoxins produced by these bacteria are the primary drivers of pulpal inflammation and periapical disease (Zehnder, 2006, PubMed). Clinical treatment focuses on the eradication of these pathogens through mechanical instrumentation and chemical irrigation with agents like sodium hypochlorite (Haapasalo et al., 2010, PubMed). In cases of systemic involvement, antibiotics such as amoxicillin and metronidazole are employed to target the anaerobic components of the infection (StatPearls, 2023). Persistent infection by these bacteria is the leading cause of endodontic treatment failure and the development of chronic apical periodontitis.
Antimicrobial agents target these bacteria through various mechanisms: beta-lactams (e.g., amoxicillin) inhibit cell wall synthesis; nitroimidazoles (e.g., metronidazole) create reactive intermediates that cause DNA strand breakage; lincosamides (e.g., clindamycin) bind to the 50S ribosomal subunit to inhibit protein synthesis; and oxidizing agents (e.g., sodium hypochlorite) cause biosynthetic alterations and protein dissolution (StatPearls, 2023; NIH, 2022).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oral anaerobic root canal bacteria.